HUTCHMED (HCM) News Today GBX 256 +15.00 (+6.22%) As of 02/21/2025 11:46 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period HUTCHMED (LON:HCM) Share Price Passes Below Two Hundred Day Moving Average - What's Next?HUTCHMED (LON:HCM) Shares Pass Below Two Hundred Day Moving Average - Here's WhyFebruary 18, 2025 | marketbeat.comHUTCHMED (LON:HCM) Stock Price Crosses Below 200-Day Moving Average - Time to Sell?HUTCHMED (LON:HCM) Stock Price Crosses Below 200 Day Moving Average - What's Next?February 8, 2025 | marketbeat.comHUTCHMED (LON:HCM) Shares Pass Below 200-Day Moving Average - What's Next?HUTCHMED (LON:HCM) Shares Cross Below 200-Day Moving Average - Here's WhyJanuary 31, 2025 | marketbeat.comHutchmed delays circular on $608 million joint venture saleJanuary 28, 2025 | msn.comHUTCHMED (LON:HCM) Stock Crosses Below 200 Day Moving Average - Here's What HappenedHUTCHMED (LON:HCM) Shares Cross Below Two Hundred Day Moving Average - Should You Sell?January 23, 2025 | marketbeat.comHUTCHMED (LON:HCM) Shares Cross Below 200-Day Moving Average - What's Next?HUTCHMED (LON:HCM) Stock Crosses Below 200 Day Moving Average - Here's What HappenedJanuary 15, 2025 | marketbeat.comHUTCHMED Announces NMPA Full Approval for ORPATHYS® (savolitinib) in China for Patients with Locally Advanced or Metastatic MET Exon 14 NSCLCJanuary 13, 2025 | markets.businessinsider.comHutchmed price target lowered to $26 from $30 at BofAJanuary 7, 2025 | markets.businessinsider.comPrivate equity firms are HUTCHMED (China) Limited's (LON:HCM) biggest owners and were rewarded after market cap rose by UK£120m last weekJanuary 5, 2025 | finance.yahoo.comChinese regulators accept NDA for Orpathys/Tagrisso comboJanuary 2, 2025 | msn.comHutchmed divests 45% interest in Shanghai Hutchison for $608MJanuary 1, 2025 | markets.businessinsider.comHUTCHMED Announces US$608 million Divestment of Non-Core Joint VentureJanuary 1, 2025 | markets.businessinsider.comHUTCHMED Divests 45% Stake In Shanghai Hutchison Pharmaceuticals For $608 MlnJanuary 1, 2025 | markets.businessinsider.comHUTCHMED to divest 45% stake in JV with Shanghai PharmaJanuary 1, 2025 | msn.comHUTCHMED (LON:HCM) Shares Pass Below Two Hundred Day Moving Average - Should You Sell?HUTCHMED (LON:HCM) Stock Crosses Below 200 Day Moving Average - Here's WhyDecember 28, 2024 | marketbeat.comHUTCHMED (LON:HCM) Stock Crosses Below Two Hundred Day Moving Average - Here's WhyHUTCHMED (LON:HCM) Stock Price Crosses Below 200-Day Moving Average - Time to Sell?December 20, 2024 | marketbeat.comHUTCHMED (China) Limited: HUTCHMED to Receive Milestone Payment from Takeda following First European Reimbursement for FRUZAQLA (fruquintinib)December 13, 2024 | finanznachrichten.deHUTCHMED (LON:HCM) Shares Down 3.7% - Here's What HappenedHUTCHMED (LON:HCM) Shares Down 3.7% - Should You Sell?December 12, 2024 | marketbeat.comHUTCHMED: ORPATHYS And TAGRISSO Get Breakthrough Therapy Designation In China For NSCLCDecember 12, 2024 | markets.businessinsider.comHUTCHMED Receives NMPA Conditional Approval For TYVYT Combination In Advanced Endometrial CancerDecember 4, 2024 | markets.businessinsider.comHUTCHMED (China) Limited: HUTCHMED Announces Launch by Takeda of FRUZAQLA (fruquintinib) in JapanNovember 22, 2024 | finanznachrichten.deHUTCHMED To Receive Milestone Payment As Takeda Launches FRUZAQLA For Colorectal Cancer In JapanNovember 22, 2024 | markets.businessinsider.comHUTCHMED (LON:HCM) Share Price Passes Below Two Hundred Day Moving Average - Here's WhyHUTCHMED (LON:HCM) Share Price Passes Below 200 Day Moving Average - What's Next?November 16, 2024 | marketbeat.comHutchmed to receive $20M milestone payment from Takeda for Fruzaqla salesOctober 31, 2024 | markets.businessinsider.comHUTCHMED (LON:HCM) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?HUTCHMED (LON:HCM) Stock Price Crosses Above Two Hundred Day Moving Average - Here's WhyOctober 26, 2024 | marketbeat.comHUTCHMED (LON:HCM) Shares Pass Above 200-Day Moving Average - Time to Sell?HUTCHMED (LON:HCM) Stock Crosses Above 200 Day Moving Average - What's Next?October 16, 2024 | marketbeat.comHUTCHMED (China) Ltd (HCM) (Q2 2024) Earnings Call Highlights: Strong US Sales Propel Growth ...October 9, 2024 | finance.yahoo.comHUTCHMED (LON:HCM) Share Price Crosses Above 200 Day Moving Average of $284.47HUTCHMED (LON:HCM) Stock Crosses Above Two Hundred Day Moving Average of $284.47September 28, 2024 | marketbeat.comHUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by TakedaSeptember 24, 2024 | markets.businessinsider.comHutchmed Share Chat (HCM)September 20, 2024 | lse.co.ukHUTCHMED (LON:HCM) Stock Crosses Below 200 Day Moving Average of $281.77HUTCHMED (LON:HCM) Shares Pass Below Two Hundred Day Moving Average of $281.77September 4, 2024 | marketbeat.comHUTCHMED (China) Limited: HUTCHMED Provides Update on Fruquintinib for Second-Line Gastric Cancer in ChinaAugust 31, 2024 | finanznachrichten.deHUTCHMED (LON:HCM) Stock Crosses Below Two Hundred Day Moving Average of $280.85HUTCHMED (LON:HCM) Shares Cross Below 200-Day Moving Average of $280.85August 27, 2024 | marketbeat.comRobust Sales and Expansion Potential Underpin Buy Rating for HUTCHMEDAugust 5, 2024 | markets.businessinsider.com0J7G.IL,0P0001HOP9,145 (0J7G.IL)August 4, 2024 | ca.finance.yahoo.comHCM Aug 2024 25.000 callAugust 4, 2024 | ca.finance.yahoo.comHUTCHMED (China) Limited's (LON:HCM) last week's 6.4% decline must have disappointed private equity firms who have a significant stakeJuly 29, 2024 | finance.yahoo.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM) and PAVmed (PAVM)May 15, 2024 | markets.businessinsider.comHUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board CommitteeMay 8, 2024 | markets.businessinsider.comHUTCHMED (China) (LON:HCM) shareholders are up 8.2% this past week, but still in the red over the last five yearsApril 24, 2024 | finance.yahoo.comHUTCHMED (China) Ltd ADRApril 21, 2024 | morningstar.comLONDON BRIEFING: JD Sports backs outlook; Spirent accepts new offerMarch 28, 2024 | lse.co.ukHCM Mar 2024 30.000 callMarch 15, 2024 | finance.yahoo.comHUTCHMED Hold Rating: Cautious Optimism Amidst Stable Outlook and International Growth PotentialFebruary 28, 2024 | markets.businessinsider.comHUTCHMED (China) Limited: HUTCHMED Reports 2023 Full Year Results and Provides Business UpdatesFebruary 28, 2024 | finanznachrichten.deHutchison China MediTech reports FY resultsFebruary 28, 2024 | msn.comHUTCHMED Reports 2023 Full Year Results and Provides Business UpdatesFebruary 28, 2024 | markets.businessinsider.comHUTCHMED Turns To Profit In FY23, Revenue Surges; Stock Up In Pre-marketFebruary 28, 2024 | markets.businessinsider.comHUTCHMED (China) Ltd (H7T2.BE)February 20, 2024 | au.finance.yahoo.comHUTCHMED (China) Limited's (LON:HCM) biggest owners are private equity firms who got richer after stock soared 4.3% last weekFebruary 20, 2024 | finance.yahoo.com Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address HCM Media Mentions By Week HCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCM News Sentiment▼1.110.60▲Average Medical News Sentiment HCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCM Articles This Week▼10▲HCM Articles Average Week Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ITH News Today GRI News Today INDV News Today BMY News Today GPH News Today IGC News Today ARTL News Today PHAR News Today KOD News Today MRK News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:HCM) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
